Lectuer 6 Flashcards

1
Q

what the body does to a drug . This statement refers to ?

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mention the four pharmacokinetic parameters :

A

• Absorption: First, absorption from the site of administration permits entry of the drug (either directly or indirectly) into plasma.
• Distribution: Second, the drug may then reversibly leave the bloodstream and distribute into the interstitial and intracellular fluids.
• Metabolism: Third, the drug may be bio-transformed by metabolism by the liver or other tissues.
• Elimination: Finally, the drug and its metabolites are eliminated from the body in urine, bile, or feces.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The four pharmacokinetic parameters determine ?

A

The onset, intensity, and the duration of drug action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Using knowledge of pharmacokinetic parameters, clinicians can design optimal drug regimens including:

A

✔ The route of administration
✔ The dose
✔ The frequency
✔ The duration of treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The drug is absorbed into the ………

A

Plasma ( blood🩸)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The drug is distributed from the …….. to the …….

A
  1. plasma
  2. tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The metabolism occurs in?

A

Tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Elimination occurs through several ways , mention them :

A
  1. Bile
  2. Breast milk
  3. Urine
  4. Sweat
  5. Feces
  6. Tears
  7. Saliva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

…………… is the transfer of a drug from the site of administration to the bloodstream.

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The rate and extent of absorption depend on ?

A

• The environment where the drug is absorbed
• The chemical characteristics of the drug,
• The route of administration (which influences bioavailabiliy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Routes of administration may result in partial absorption and lower bioavailability .EXCEPT :

A

Intravenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mention the mechanisms of drug absorption

A

❑ Passive diffusion
❑ Facilitated diffusion
❑ Active transport
❑ Endocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give me the features of Passive Diffusion

A

✔ The driving force is the concentration gradient
✔ Does not involve a carrier, is not saturable, and shows a low structural specificity.
✔ Water-soluble drugs: aqueous channels or pores
✔ Lipid-soluble drugs: biologic membranes due to their solubility in the membrane lipid bilayers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give me the features of facilitated Diffusion :

A

• Enter molecules into the interior of cells and moving them from an area of high concentration to an area of low concentration.
• Molecules enter the cell through specialized transmembrane carrier proteins that facilitate the passage of large molecules (conformational changes)
• It does not require energy, can be saturated,
•May be inhibited by compounds that compete for the carrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give me the features of active transport :

A

• Moving drugs against a concentration gradient, from a region of low drug concentration to one of higher drug concentration (using ATP)
• Drug entry involves specific carrier proteins that span the membrane
•The process is saturable.
• Active transport systems
are selective .
• May be competitively inhibited by other co-transported substances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give me the features of endocytosis :

A

• Used to transport drugs of exceptionally large size across the cell membrane
• Involves engulfment of a drug by the cell membrane and transport into the cell by pinching off the drug-filled vesicle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The reverse of endocytosis named as ?

A

Exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Many cells use exocytosis to secrete substances out of the cell through a similar process of vesicle formation . (T/F) ?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

There are many factors influencing absorption , mention them :

A
  1. Effect of PH on drug absorption
  2. Blood flow to the absorption site
  3. Total surface area available for absorption
  4. Contact time at the absorption surface
  5. Expression of P-glycoprotein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

We have weak acids such as (HA) which release ………… causing ……….

A
  1. proton (H+)
  2. charged anion (A−)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Weak bases (BH+) can’t release an H+. (T/F) ?

A

F —> Weak bases (BH+) can also release an H+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

A drug passes through membranes more readily if it is charged , ( yes/no) ?

A

No , uncharged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Protonated acid HA and un-protonated base B are ( less/ more ) absorbable ?

A

More

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Effective concentration of the permeable form of each drug at its absorption site is determined by ?

A

The relative concentrations of the charged and uncharged forms .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

The ratio between the two forms ( acid / base) is determined by the ?

A
  1. pH at the site of absorption
  2. The strength of the weak acid or base (pKa) .
26
Q

measure of the strength of the interaction of a compound with a proton is called ?

A

The ionization constant (pKa)

27
Q

The higher the pKa of a drug, the less acidic it is .(T/F) ?🌚

A

True

28
Q

When pH is less than pk ,
the protonated forms
HA and BH+ predominate . (T/F) ?

A

True

29
Q

When pH is greater than pk , the protonated forms
A- and B predominate,

A

T

30
Q

The intestines receive less blood flow than the stomach, so absorption from the stomach is favoured over the intestine .

A

F—> (The intestines receive much more blood flow than the stomach, so absorption from the intestine is favoured over the stomach).💀

31
Q

Some disease conditions alter blood flow to some organs and subsequently drug absorption . Give me example to explain this statement:

A

Shock severely reduces blood flow to cutaneous tissues, thereby minimizing absorption from SC (subcutaneous) administration

32
Q

The intestine has a surface area about 1000-fold that of the stomach because?

A

The intestine have a surface rich in brush borders which containing microvilli .

33
Q

💕 صلِّ على سيدنا محمد 💕
💕 لا حول ولا قوة إلا بالله 💕
💕 استغفر الله العظيم واتوب إليه💕

A

(( والله في عون العبد ما دام العبد في عون أخيه)) 🤍🌿

34
Q

• If a drug moves through the GI tract very quickly (diarrhea), it is not well absorbed. This statement is an example of

A

Contact time at the absorption surface

35
Q

Anything that delays the transport of the drug from the stomach to the intestine delays the rate of absorption of the drug . (T/F) ?

A

True

36
Q

Presence of food in the stomach lead to ?

A

Dilutes the drug and slows gastric emptying.

37
Q

P-glycoprotein is ?

A

Transmembrane transporter protein

38
Q

Where the Transmembrane transporter protein (P-glycoprotein) expressed ?

A

It is expressed in the liver, kidneys, placenta, intestines, and brain capillaries.

39
Q

P-glycoprotein involved in transportation of drugs from ?

A

tissues to blood.

40
Q

P-glycoprotein “pumps” drugs out of the cells .(T/F) ?

A

True

41
Q

In areas of high expression, it (increases / reduces) drug absorption.

A

Reduces

42
Q

P-glycoprotein also associated with ……. ?

A

multidrug resistance.

43
Q

The rate and extent to which an administered drug reaches the systemic circulation is called ?

A

Bioavailability

44
Q

If 100 mg of a drug is administered orally and 70 mg is absorbed unchanged, the bioavailability is ?

A

0.7 or 70%.

45
Q

The importance of bioavailability is ?

A

important for calculating drug dosages for non-intravenous routes of administration.

46
Q

It is determined by ?

A

comparing plasma levels of a drug after a particular ROA with levels achieved by IV administration.

47
Q

The area under the curve (AUC) can be measured by ?

A

By plotting plasma concentrations of the drug versus time .

48
Q

Bioavailability of a drug given orally is the ratio of ?

A

The AUC following oral administration to the AUC following IV administration.
AUC (oral) / AUC (IV) .

49
Q

Mention the factors that influence bioavailability :

A

• First-pass hepatic metabolism
• Solubility of the drug
• Chemical instability
• Nature of the drug formulation

50
Q

If the drug is rapidly metabolized in the liver or gut wall during this initial passage, the amount of unchanged drug entering the systemic circulation is decreased. This statement describe?

A

First-pass hepatic metabolism

51
Q

Give me example about first-pass hepatic metabolism :

A

(Nitroglycerin , Levofloxacin)

52
Q

Give me the absorption power ( poorly , readily , ….. ) of each of the following :
1. Very hydrophilic drugs:
2. Extremely lipophilic drugs:
3. Largely lipophilic , yet have some solubility in aqueous solutions drugs:

A
  1. poorly absorbed
  2. poorly absorbed
  3. readily absorbed
53
Q

unstable in the pH of the gastric contents. This statement is an example of ?

A

Chemical instability
( Penicillin G )

54
Q

Destroyed in the GI tract by degradative enzymes . This statement is an example of ?

A

Chemical instability
(Insulin)

55
Q

Mention the examples that can influence the ease of dissolution and, therefore, alter the rate of absorption :

A
  1. Particle size
  2. salt form
  3. crystal polymorphism
  4. enteric coatings
  5. and the presence of excipients (such as binders and dispersing agents)
56
Q

Two drug formulations are bioequivalent if ?

A

They show comparable bioavailability and similar times to achieve peak blood concentrations .

57
Q

they have the same dosage form, contain the same active ingredient, and use the same route of administration . This statement describe related to ?

A

pharmaceutically equivalent

58
Q

Define the therapeutic equivalence .

A

Drugs should be pharmaceutically equivalent (that is, they have the same dosage form, contain the same active ingredient, and use the same route of administration) with similar clinical and safety profiles .

59
Q

The clinical effectiveness of therapeutic equivalence is ?

A

maximum serum drug concentration (Cmax) and the time required (after administration) to reach peak concentration (Tmax).

60
Q

Two drugs that are bioequivalent may not be therapeutically equivalent.(T/F) ?

A

True —> very important question